EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED

This adverse event was reported 611 times

These drugs are most commonly taken by patients reporting EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED:

# Drug Count
0 NIRAPARIB 127
1 PEMBROLIZUMAB 56
2 BEVACIZUMAB 52
3 CARBOPLATIN 43
4 PACLITAXEL 39
5 RIBOCICLIB 39
6 DEXAMETHASONE 34
7 DEXAMETHASONE 1.5 MG 34
8 GABAPENTIN 29
9 ACETAMINOPHEN 26
See all common drugs associated with EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED

EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 METAPROTERENOL SULFATE 1 0.0233
1 AMCINONIDE 1 0.0133
2 NIRAPARIB 127 0.0098
3 ENASIDENIB MESYLATE 15 0.0078
4 SILTUXIMAB 2 0.0074
5 CEDAZURIDINE AND DECITABINE 1 0.0064
6 METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE 1 0.0055
7 RIBOCICLIB 39 0.0035
8 BRIGATINIB 5 0.0031
9 ADO-TRASTUZUMAB EMTANSINE 13 0.0030
See all drugs enriched for association with EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED